FDA authorizes Pfizer for 12-15-year-olds

The Pfizer vaccine has been authorized for children ages 12 and up, the FDA announced Monday, bolstering chances for a safe return to full time school in the fall.

The Pfizer vaccine has been authorized for children ages 12 and up, widening the U.S. population that will be protected against the virus and bolstering chances for a safe return to full time school in the fall, the Food and Drug Administration announced Monday. Pfizer announced in late March that its clinical trials showed the vaccine was safe and 100% effective in children ages 12-15, similar to the 95% efficacy among adult clinical trial participants. This is a developing news story. Please check back for updates.